Literature DB >> 6420502

Purification and partial characterization of the opacity-associated proteins of Neisseria gonorrhoeae.

M S Blake, E C Gotschlich.   

Abstract

Gonococci, grown on agar, frequently give rise to opaque colonies. This opacity phenotype is associated with the presence of one or more outer membrane proteins of approximately 28,000 mol weight. These proteins are included within a class of proteins named proteins II. A method is described to isolate and purify the opacity-associated proteins from Neisseria gonorrhoeae. This method uses high concentrations of calcium and a zwitterionic detergent at pH 4.0. Under these conditions proteins II are readily solubilized from the outer membrane. Further purification is achieved by ion exchange and molecular sieve chromatography in the presence of the zwitterionic detergent. The opacity-associated proteins are very basic with isoelectric points varying between 9.0 to 10.0. Further evidence for their basic nature is their behavior on ion exchange chromatography and their amino acid composition.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6420502      PMCID: PMC2187218          DOI: 10.1084/jem.159.2.452

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Studies on gonococcus infection. XIII. Occurrence of color/opacity colonial variants in clinical cultures.

Authors:  J F James; J Swanson
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

2.  Studies on gonococcus infection. XII. Colony color and opacity varienats of gonococci.

Authors:  J Swanson
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

3.  Purification and partial characterization of the major outer membrane protein of Neisseria gonorrhoeae.

Authors:  M S Blake; E C Gotschlich
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

4.  Altered outer membrane protein in different colonial types of Neisseria gonorrhoeae.

Authors:  D L Walstad; L F Guymon; P F Sparling
Journal:  J Bacteriol       Date:  1977-03       Impact factor: 3.490

5.  Reconstitution of maltose transport in malB mutants of Escherichia coli through calcium-induced disruptions of the outer membrane.

Authors:  J M Brass; W Boos; R Hengge
Journal:  J Bacteriol       Date:  1981-04       Impact factor: 3.490

6.  Complete amino acid analysis of proteins from a single hydrolysate.

Authors:  R J Simpson; M R Neuberger; T Y Liu
Journal:  J Biol Chem       Date:  1976-04-10       Impact factor: 5.157

7.  Domains involving nonrandom distribution of lipopolysaccharide in the outer membrane of Escherichia coli.

Authors:  L Leive
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

8.  Vertical displacement of membrane proteins mediated by changes in microviscosity.

Authors:  H Borochov; M Shinitzky
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

9.  NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION.

Authors:  D S KELLOGG; W L PEACOCK; W E DEACON; L BROWN; D I PIRKLE
Journal:  J Bacteriol       Date:  1963-06       Impact factor: 3.490

10.  Immunological characteristics of gonococcal outer membrane protein II assessed by immunoprecipitation, immunoblotting, and coagglutination.

Authors:  J Swanson; O Barrera
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

View more
  45 in total

1.  Porin protein of Neisseria gonorrhoeae: cloning and gene structure.

Authors:  E C Gotschlich; M E Seiff; M S Blake; M Koomey
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization.

Authors:  Pooja Ralli-Jain; Delia Tifrea; Chunmei Cheng; Sukumar Pal; Luis M de la Maza
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

3.  Immunogenic activity of gonococcal protein I in mice with three different lipoidal adjuvants delivered in liposomes and in complexes.

Authors:  W Jiskoot; T Teerlink; M M Van Hoof; K Bartels; V Kanhai; D J Crommelin; E C Beuvery
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

4.  Purification and antigenic relatedness of proteins II of Neisseria gonorrhoeae.

Authors:  L B Mail; C E Wilde; R B Jones
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

5.  Bordetella pertussis major outer membrane porin protein forms small, anion-selective channels in lipid bilayer membranes.

Authors:  S K Armstrong; T R Parr; C D Parker; R E Hancock
Journal:  J Bacteriol       Date:  1986-04       Impact factor: 3.490

6.  Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria.

Authors:  Sukumar Pal; Ellena M Peterson; Luis M de la Maza
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 7.  Rho GTPases as pathogen targets: Focus on curable sexually transmitted infections.

Authors:  Cristián A Quintero; Julián Gambarte Tudela; María T Damiani
Journal:  Small GTPases       Date:  2015-05-29

8.  Chemical characterization of binding properties of opacity-associated protein II from Neisseria gonorrhoeae.

Authors:  D Bessen; E C Gotschlich
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

9.  Defining targets for complement components C4b and C3b on the pathogenic neisseriae.

Authors:  Lisa A Lewis; Sanjay Ram; Alpana Prasad; Sunita Gulati; Silke Getzlaff; Anna M Blom; Ulrich Vogel; Peter A Rice
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

10.  Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein.

Authors:  Guifeng Sun; Sukumar Pal; Joseph Weiland; Ellena M Peterson; Luis M de la Maza
Journal:  Vaccine       Date:  2009-05-27       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.